A Phase I Dose-escalation Study of a Single Administration of Extended-Release Injectable Suspension (ND-340)
Clinical trial NCT04515953 · SUSPENDED
Trial details
- NCT number
- NCT04515953
- Sponsor
- Nang Kuang Pharmaceutical Co., Ltd.
- Status
- SUSPENDED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-15
- Primary completion
- 2025-12-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.